26 May 2013
Keywords: once-daily, xibrom, effective, ph, iii, study, california
Article | 19 February 2007
California, USA-based drugmaker ISTA Pharmaceuticals says that the preliminary analysis of results from a series of Phase III trials of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com